Amryt Pharma PLC (LON:AMYT) is set to issue its quarterly earnings data before the market opens on Monday, September 11th.

Shares of Amryt Pharma PLC (LON AMYT) opened at 22.75 on Friday. Amryt Pharma PLC has a one year low of GBX 13.44 and a one year high of GBX 29.50. The company’s market capitalization is GBX 47.40 million. The firm’s 50-day moving average price is GBX 21.61 and its 200-day moving average price is GBX 22.13.

COPYRIGHT VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/09/09/amryt-pharma-plc-amyt-scheduled-to-post-quarterly-earnings-on-monday.html.

Separately, Beaufort Securities reissued a “speculative buy” rating and set a GBX 62 ($0.80) price target on shares of Amryt Pharma PLC in a research report on Thursday, August 31st.

Amryt Pharma PLC Company Profile

Amryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses. The Company’s lead products include AP 101 and AP102.

Receive News & Stock Ratings for Amryt Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma PLC and related stocks with our FREE daily email newsletter.